Avalon Investment & Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-24,766
Closed -$2.69M – 348
2018
Q4
$2.69M Buy
24,766
+1,223
+5% +$164K 0.07% 187
2018
Q3
$3.51M Buy
23,543
+1,649
+8% +$251K 0.1% 187
2018
Q2
$3.38M Buy
21,894
+1,952
+10% +$295K 0.1% 177
2018
Q1
$2.77M Buy
19,942
+1,920
+11% +$282K 0.09% 181
2017
Q4
$2.47M Buy
18,022
+6,534
+57% +$863K 0.08% 184
2017
Q3
$1.49M Sell
11,488
-83
-0.7% -$11.1K 0.05% 206
2017
Q2
$1.53M Sell
11,571
-13,292
-53% -$1.63M 0.05% 207
2017
Q1
$3.06M Buy
24,863
+2,336
+10% +$277K 0.11% 146
2016
Q4
$2.48M Buy
22,527
+221
+1% +$24.6K 0.09% 141
2016
Q3
$2.63M Buy
+22,306
New +$2.63M 0.1% 124

Other funds holding LH

Avalon Investment & Advisory's LH Position: Q1 2019 in Review

Avalon Investment & Advisory sold out of Labcorp (LH) in Q1 2019, closing a stake of 24,766 shares — an estimated $2.69M sold.

Avalon Investment & Advisory first reported a position in LH in Q3 2016 and held it in 10 quarters. The position peaked at $3.51M in Q3 2018. 745 funds tracked by Wall St. Rank hold LH as of Q1 2019.

  • Avalon Investment & Advisory reported no remaining Labcorp position as of Q1 2019 after selling out during the quarter.
  • Avalon Investment & Advisory sold 24,766 Labcorp shares in Q1 2019, an estimated $2.69M.
  • Avalon Investment & Advisory first reported a position in Labcorp in Q3 2016 and held it in 10 quarters.
  • Avalon Investment & Advisory's Labcorp position peaked at $3.51M in Q3 2018.
  • 745 funds tracked by Wall St. Rank held Labcorp as of Q1 2019.

Based on Avalon Investment & Advisory's 13F filing for Q1 2019, filed 24 Apr 2019.